All Therapeutic Areas
🎗️
Oncology
244 drugs in pipeline from 10 companies
244
Drugs in Pipeline
10
Companies
10
Upcoming Catalysts
244
Phase 3 Trials
Upcoming Catalysts
Sep '26
Sacituzumab Govitecan-hziy Phase 3 Est. Readout
Sacituzumab Govitecan-hziy443
Sep '26
Sep '26
Sep '26
Sep '26
Sep '26
Pipeline by Phase
Phase 3
244
Active Companies
MRK
8 drugsMERCK
CELG-RI
10 drugsBRISTOL MYERS SQUIBB CO
RHHBY
17 drugsRoche Holding AG
NVSEF
4 drugsNOVARTIS AG
GNMSF
7 drugsGENMAB A/S
AMGN
7 drugsAmgen Inc.
JNGHF
1 drugsJiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
JNJ
2 drugsJohnson & Johnson
AZNCF
17 drugsASTRAZENECA PLC
JHPCY
6 drugsJiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
Related Conditions
cancertumorcarcinomalymphomaleukemiamelanomaoncologysarcomamyelomametastaticneoplasmmalignantbreast cancerlung cancerprostate cancercolorectalpancreaticglioblastomahepatocellularrenal cellovarianbladdernsclcsclcamlcllalldlbclhodgkinnon-hodgkin
